Coleman Mark
Insider CIK 1658379 · AXSM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-10 | 643 | $249.00 | $160.1K | 30,389 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 31,032 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-06-05 | 2026-06-09 | 1,721 | — | $0 | 1,721 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-02 | 2026-06-02 | 5,537 | $223.39 | $1.24M | 29,603 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-01 | 2026-06-02 | 6,000 | $230.30 | $1.38M | 35,140 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-05-29 | 2026-06-02 | 6,000 | $233.46 | $1.40M | 41,140 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-02-26 | 2026-02-27 | 25,000 | $161.11 | $4.03M | 47,140 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-02-23 | 2026-02-25 | 6,250 | — | $0 | 7,721 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-02-23 | 2026-02-25 | 6,250 | $4.95 | $30.9K | 72,140 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-02-20 | 2026-02-23 | 12,485 | — | $0 | 13,971 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-02-20 | 2026-02-23 | 12,485 | $4.95 | $61.8K | 65,890 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-02-10 | 2026-02-10 | 5,193 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-02-10 | 2026-02-10 | 5,193 | $8.02 | $41.6K | 53,405 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2025-09-08 | 2025-09-09 | 800 | $127.20 | $101.8K | 47,437 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2025-09-08 | 2025-09-09 | 488 | $127.40 | $62.2K | 48,212 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2025-09-08 | 2025-09-09 | 287 | $127.30 | $36.5K | 47,724 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 3,166 | — | $0 | 3,166 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 1,429 | — | $0 | 1,429 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-05-28 | 2025-05-29 | 3,750 | $103.43 | $387.9K | 46,637 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-05-27 | 2025-05-29 | 3,750 | $105.47 | $395.5K | 50,387 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-05-20 | 2025-05-20 | 3,000 | $107.49 | $322.5K | 54,137 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-01-03 | 2025-01-06 | 9,127 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-01-03 | 2025-01-06 | 9,127 | $9.00 | $82.1K | 57,137 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-11-19 | 2024-11-20 | 33,410 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-11-19 | 2024-11-20 | 33,410 | $5.94 | $198.5K | 48,010 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 5,799 | — | $0 | 5,799 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-05-29 | 2024-05-29 | 5,248 | $75.14 | $394.3K | 14,600 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-29 | 5,249 | $75.21 | $394.8K | 19,848 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2023-09-15 | 2023-09-15 | 11,016 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-15 | 11,016 | $75.19 | $828.3K | 25,097 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-15 | 11,016 | $3.67 | $40.4K | 36,113 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-15 | 18,572 | $75.18 | $1.40M | 403,856 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 5,681 | — | $0 | 5,681 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 2,870 | — | $0 | 2,870 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2023-01-03 | 2023-01-04 | 17,501 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2023-01-03 | 2023-01-04 | 17,501 | $1.30 | $22.8K | 25,097 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 16,976 | — | $0 | 16,976 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2022-03-15 | 2022-03-17 | 3,496 | — | $0 | 17,501 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2022-03-15 | 2022-03-17 | 3,496 | $1.30 | $4.5K | 7,596 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 2,798 | — | $0 | 2,798 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 409 | $35.07 | $14.3K | 421,407 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 1,021 | $35.10 | $35.8K | 422,428 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 7,325 | — | $0 | 7,325 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-05-12 | 2021-05-13 | 500 | $58.15 | $29.1K | 420,998 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 1,201 | — | $0 | 1,201 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | G Gift | 2020-08-19 | 2020-08-20 | 397,998 | — | $0 | 397,998 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | G Gift | 2020-08-19 | 2020-08-20 | 397,998 | — | $0 | 5,700 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2020-06-29 | 2020-06-30 | 650 | $78.50 | $51.0K | 403,698 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 3,308 | — | $0 | 3,308 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-06-26 | 2019-06-27 | 15,800 | $23.10 | $365.0K | 668,848 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-06-25 | 2019-06-27 | 400 | $23.25 | $9.3K | 653,048 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-05-13 | 2019-05-15 | 4,650 | $21.44 | $99.7K | 652,648 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 25,652 | — | $0 | 25,652 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-03-19 | 2019-03-21 | 5,100 | $12.18 | $62.1K | 5,100 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-04-05 | 27,297 | — | $0 | 27,297 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 26,456 | — | $0 | 26,456 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2016-05-27 | 2016-06-01 | 5,193 | — | $0 | 5,193 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 243,750 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 180,526 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 140,672 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 180,526 | $5.94 | $1.07M | 507,326 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 243,750 | $5.40 | $1.32M | 326,800 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 140,672 | $5.94 | $835.6K | 647,998 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-19 | 2015-11-23 | 9,127 | — | $0 | 9,127 | SEC↗ |